Free Trial Information
BioCentury | Jul 16, 2012
Finance

Tool story

...Inc. (NYSE:CRL), Covance Inc. (NYSE:CVD), Danaher Corp. (NYSE:DHR), ICON plc (NASDAQ:ICLR), Life Technologies Corp. (NASDAQ:LIFE), Mettler-Toledo International Inc....
Read More
BioCentury | Aug 13, 2007
Company News

Addex Pharmaceuticals S.A. board of directors update

Addex Pharmaceuticals S.A. , Geneva, Switzerland Business: Neurology Appointed: Jacques Theurillat, former deputy CEO and SVP of corporate strategic development at Serono S.A. , now part of Merck KGaA 's Merck Serono S.A. subsidiary; and Beat Luethi,...
Read More
BioCentury | Apr 5, 2004
Company News

Solexa Ltd. board of directors update

...U.K. Business: Microarrays, Chemistry, Genomics Appointed: Stephen Allen, head of the automated chemistry division at Mettler-Toledo...
Read More
Items per page:
1 - 3 of 3
BioCentury | Jul 16, 2012
Finance

Tool story

...Inc. (NYSE:CRL), Covance Inc. (NYSE:CVD), Danaher Corp. (NYSE:DHR), ICON plc (NASDAQ:ICLR), Life Technologies Corp. (NASDAQ:LIFE), Mettler-Toledo International Inc....
Read More
BioCentury | Aug 13, 2007
Company News

Addex Pharmaceuticals S.A. board of directors update

Addex Pharmaceuticals S.A. , Geneva, Switzerland Business: Neurology Appointed: Jacques Theurillat, former deputy CEO and SVP of corporate strategic development at Serono S.A. , now part of Merck KGaA 's Merck Serono S.A. subsidiary; and Beat Luethi,...
Read More
BioCentury | Apr 5, 2004
Company News

Solexa Ltd. board of directors update

...U.K. Business: Microarrays, Chemistry, Genomics Appointed: Stephen Allen, head of the automated chemistry division at Mettler-Toledo...
Read More
Items per page:
1 - 3 of 3